CYTOKINE TREATMENT OF ENDOTHELIAL-CELLS INCREASES GLYCOPROTEIN IB-ALPHA-DEPENDENT ADHESION TO VON-WILLEBRAND-FACTOR

Citation
Da. Beacham et al., CYTOKINE TREATMENT OF ENDOTHELIAL-CELLS INCREASES GLYCOPROTEIN IB-ALPHA-DEPENDENT ADHESION TO VON-WILLEBRAND-FACTOR, Blood, 89(11), 1997, pp. 4071-4077
Citations number
41
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
89
Issue
11
Year of publication
1997
Pages
4071 - 4077
Database
ISI
SICI code
0006-4971(1997)89:11<4071:CTOEIG>2.0.ZU;2-C
Abstract
Endothelial cells (EC) possess at least two membrane receptors for von Willebrand factor (vWF),the vitronectin receptor (VNR, alpha(v) beta( 3)), which recognizes an Arg-Gly-Asp (RGD) sequence in the C-terminus of vWF, and glycoprotein Ib alpha (GP Iba), which interacts with a reg ion in the N-terminal Al domain of VWF. In the absence of added cytoki nes, EC attachment to a VWF substratum is mediated largely through the alpha(v) beta(3), with a smaller contribution by GP Ib alpha. In the present study, we have examined the effect of cytokines on the recepto r specificity of EC attachment to wild-type vWF (WT-vWF) and to vWF, w hich had been mutated in the C-terminal RGDS sequence (RADS-vWF). Expo sure of human umbilical vein EC (HUVEC) to tumor necrosis factor-alpha (TNF-alpha) or to TNF-alpha in combination with interferon-gamma (IFN -gamma), but not to interleukin-1 beta (IL-l), increased attachment to RADS-vWF by about twofold. The TNF-alpha-induced increase in EC attac hment was accompanied by an increase in cell surface GP Ib alpha expre ssion; GP Ib alpha surface expression was not increased by IL-l. Attac hment of untreated HUVEC to WT-vWF could be inhibited 60% to 70% by a monoclonal antibody (MoAb) (LM609) to the VNR and 30% to 40% by the Al fragment of VWF (containing the GP Ib alpha binding domain). The patt ern of inhibition of attachment to WT-vWF was largely unchanged after TNF-alpha treatment of HUVEC. In contrast, the attachment to WT-vWF of HUVEC, treated with TNF-alpha +IFN-gamma was completely inhibited by vWF-A1 and inhibited only 35% by the anti-VNR antibody LM609. Two MoAb s to GP Iba produced similar, but incomplete, inhibition. Pretreatment of HUVEC with the combination of TNF-alpha +IFN-gamma produced a dram atic decrease in VNR expression, confirming previous findings of Defil ippi et al. These results suggest that in the presence of the inflamma tory cytokines TNF-alpha + IFN-gamma, the endothelial GP Ib complex is a major determinant of HUVEC adhesion to surface-bound vWF. (C) 1997 by The American Society of Hematology.